Extended interval aminoglycoside dosing: from concept to clinic (Q34615905)

3 August 2017

1 reference

title

Extended interval aminoglycoside dosing: from concept to clinic (English)

1 reference

3 August 2017

3

David P Nicolau

1 reference

3 August 2017

Dana Maglio

1

1 reference

3 August 2017

Charles H Nightingale

series ordinal

2

1 reference

3 August 2017

publication date

1 April 2002

1 reference

International Journal of Antimicrobial Agents

3 August 2017

published in

1 reference

3 August 2017

volume

19

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

341-348

1 reference

Aminoglycosides: nephrotoxicity

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Feasibility of Administering Aminoglycoside Antibiotics by Continuous Intravenous Infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Amikacin therapy of infections in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Daily single-dose gentamicin therapy in experimental pyelonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

The Influence of Dosage Regimen on Experimental Gentamicin Nephrotoxicity: Dissociation of Peak Serum Levels from Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Once-daily aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Aminoglycoside Ototoxicity: Influence of Dosage Regimen on Drug Uptake and Correlation between Membrane Binding and some Clinical Features

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

The pharmacodynamics of aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Postantibiotic suppression of bacterial growth

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Kinetics of antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

The postantibiotic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Comparison of gentamicin dosing regimens using an in-vitro model.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

In vivo postantibiotic effect in a thigh infection in neutropenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

What is the evidence for once-daily aminoglycoside therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

1 reference

7 January 2021

Single daily dose of aminoglycosides--a concept whose time has not yet come

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

The pharmacokinetics of once daily gentamicin in neutropenic adults with haematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Tobramycin population pharmacokinetics in neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

An extended interval dosing method for gentamicin in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Easier monitoring of aminoglycoside therapy with once-daily dosing schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Aminoglycosides--50 years on

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Effectiveness and safety of once-daily aminoglycosides: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Single or multiple daily doses of aminoglycosides: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

National survey of extended-interval aminoglycoside dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900030-4

7 January 2021

10.1016/S0924-8579(02)00030-4

Identifiers

DOI

1 reference

3 August 2017

1 reference